Barclays PLC Increases Stake in USANA Health Sciences, Inc. (NYSE:USNA)

Barclays PLC increased its stake in shares of USANA Health Sciences, Inc. (NYSE:USNA - Free Report) by 111.9% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 27,737 shares of the company's stock after purchasing an additional 14,647 shares during the period. Barclays PLC owned 0.15% of USANA Health Sciences worth $1,052,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in USNA. Pzena Investment Management LLC grew its position in shares of USANA Health Sciences by 7.5% during the 3rd quarter. Pzena Investment Management LLC now owns 1,049,610 shares of the company's stock valued at $39,801,000 after purchasing an additional 72,977 shares in the last quarter. Dimensional Fund Advisors LP raised its position in shares of USANA Health Sciences by 0.6% during the 2nd quarter. Dimensional Fund Advisors LP now owns 683,158 shares of the company's stock valued at $30,907,000 after buying an additional 3,889 shares in the last quarter. Pacer Advisors Inc. grew its position in USANA Health Sciences by 16.5% in the third quarter. Pacer Advisors Inc. now owns 544,256 shares of the company's stock worth $20,638,000 after acquiring an additional 76,904 shares in the last quarter. State Street Corp raised its position in USANA Health Sciences by 0.6% during the third quarter. State Street Corp now owns 435,164 shares of the company's stock valued at $16,501,000 after purchasing an additional 2,782 shares in the last quarter. Finally, American Century Companies Inc. boosted its holdings in shares of USANA Health Sciences by 12.3% in the 2nd quarter. American Century Companies Inc. now owns 159,782 shares of the company's stock worth $7,229,000 after purchasing an additional 17,460 shares in the last quarter. Institutional investors own 54.25% of the company's stock.

USANA Health Sciences Stock Up 1.7 %

Shares of NYSE:USNA traded up $0.60 during midday trading on Tuesday, hitting $35.89. 81,205 shares of the stock traded hands, compared to its average volume of 84,571. The business's 50 day moving average is $37.89 and its two-hundred day moving average is $39.77. The stock has a market capitalization of $684.06 million, a PE ratio of 12.68, a P/E/G ratio of 1.25 and a beta of 0.89. USANA Health Sciences, Inc. has a one year low of $31.44 and a one year high of $54.81.

USANA Health Sciences (NYSE:USNA - Get Free Report) last announced its quarterly earnings results on Tuesday, October 22nd. The company reported $0.56 EPS for the quarter, topping analysts' consensus estimates of $0.49 by $0.07. USANA Health Sciences had a return on equity of 10.64% and a net margin of 6.30%. The company had revenue of $200.22 million during the quarter, compared to analyst estimates of $208.45 million. During the same quarter last year, the firm posted $0.59 earnings per share. As a group, sell-side analysts forecast that USANA Health Sciences, Inc. will post 2.45 earnings per share for the current year.

Wall Street Analysts Forecast Growth

USNA has been the topic of several research reports. DA Davidson raised shares of USANA Health Sciences to a "hold" rating in a research note on Friday, December 20th. StockNews.com upgraded USANA Health Sciences from a "buy" rating to a "strong-buy" rating in a report on Saturday.

Insider Activity at USANA Health Sciences

In other news, Director Gilbert A. Fuller sold 675 shares of USANA Health Sciences stock in a transaction that occurred on Monday, November 4th. The shares were sold at an average price of $37.71, for a total transaction of $25,454.25. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is currently owned by corporate insiders.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.